BSX

Boston Scientific Corporation
$44.04-$0.28-0.63%Price as of Nov 3, 2026, 9:34 AM ET

Key stats

Market cap
63.8B
Open
—
Day range
—
52-week range
$39.57 – $105.65
Volume
314K
Avg volume
18.7M

Earnings

Q3 FY26Beat
Expected$0.72
Actual$0.73
Q2 FY26
Actual$0.61
Q1 FY26
Actual$0.90
Q4 FY25
Actual$0.45

Next earnings call Feb 3, 2027

About

Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Employees
59,000
Headquarters
Marlborough, MA